Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia

Author(s):
Kroger, N.; Eikema, D.J.; Koster, L.; Beelen, D.; Wreede, L.C. de (0000-0002-7667-9369); Finke, J.; Koenecke, C.; Niederwieser, D.; Bornhauser, M.; Schoenland, S.; Potter, V.; Wolschke, C.; Maertens, J.; Theobald, M.; Kobbe, G.; Itala-Remes, M.; Wulf, G.; Kahls, P.; Forcade, E.; Greinix, H.; Masszi, T.; Yakoub-Agha, I.; Chalandon, Y.; Robin, M.; European Soc Blood Marrow Transpla
Published
2019
Publication type
Article / Letter to editor
allogeneic stem cell transplantationMDSmyeloproliferative neoplasmchronic myelomonocytic leukaemiasecondary acute myeloid leukaemia
Date issued
2019-05-31
Language
English
Is part of
British Journal of Haematology (2019), Vol. 185, no. 4, p. 725-732
hdl
1887/121453
doi
10.1111/bjh.15819